KR20150039197A - 동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 - Google Patents
동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 Download PDFInfo
- Publication number
- KR20150039197A KR20150039197A KR1020157002065A KR20157002065A KR20150039197A KR 20150039197 A KR20150039197 A KR 20150039197A KR 1020157002065 A KR1020157002065 A KR 1020157002065A KR 20157002065 A KR20157002065 A KR 20157002065A KR 20150039197 A KR20150039197 A KR 20150039197A
- Authority
- KR
- South Korea
- Prior art keywords
- cells
- therapeutic
- cell
- brain
- cns
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Virology (AREA)
- Ophthalmology & Optometry (AREA)
- Otolaryngology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Heart & Thoracic Surgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97128407P | 2007-09-11 | 2007-09-11 | |
| US60/971,284 | 2007-09-11 | ||
| US12/109,066 US8283160B2 (en) | 2007-09-11 | 2008-04-24 | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| US12/109,066 | 2008-04-24 | ||
| PCT/US2008/075223 WO2009035901A1 (en) | 2007-09-11 | 2008-09-04 | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020107007866A Division KR101504110B1 (ko) | 2007-09-11 | 2008-09-04 | 동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20150039197A true KR20150039197A (ko) | 2015-04-09 |
Family
ID=40432083
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020157002065A Ceased KR20150039197A (ko) | 2007-09-11 | 2008-09-04 | 동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 |
| KR1020107007866A Active KR101504110B1 (ko) | 2007-09-11 | 2008-09-04 | 동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020107007866A Active KR101504110B1 (ko) | 2007-09-11 | 2008-09-04 | 동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 |
Country Status (24)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8518390B2 (en) * | 2003-06-27 | 2013-08-27 | Advanced Technologies And Regenerative Medicine, Llc | Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells |
| US8283160B2 (en) | 2007-09-11 | 2012-10-09 | Frey Ii William H | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| EP2153844A1 (en) * | 2008-08-14 | 2010-02-17 | HAUBECK, Hans-Dieter | Human hyaluronidases for axonal regrowth |
| NZ591292A (en) | 2008-08-20 | 2012-10-26 | Anthrogenesis Corp | Improved cell composition and methods of making the same |
| US8609088B2 (en) | 2011-05-10 | 2013-12-17 | Regents Of The University Of Minnesota | Intranasal delivery of therapeutic enzymes to the central nervous system for the treatment of lysosomal storage diseases |
| US10022083B2 (en) | 2011-06-02 | 2018-07-17 | Abdulmohsen E. A. H. Al-Terki | Multiple oral and nasal surgical procedures method and kit |
| US8387798B1 (en) | 2012-04-27 | 2013-03-05 | Abdulmohsen E. A. H. Al-Terki | Mutiple oral and nasal surgical procedures method and kit |
| US9821149B2 (en) * | 2011-10-14 | 2017-11-21 | Healthpartners Research & Education | Methods for using ultrasound for enhancing efficiency and targeting of intranasal administration of therapeutic compounds to the central nervous system |
| KR101981450B1 (ko) | 2011-12-23 | 2019-08-28 | 디퍼이 신테스 프로덕츠, 인코포레이티드 | 인간 제대 조직-유래된 세포의 검출 |
| US20130336928A1 (en) * | 2012-06-18 | 2013-12-19 | Healthpartners Research & Education | Methods and pharmaceutical compositions for treatment of central nervous system disorders with therapeutic agent(s) in patients with concurrent non-cns condition(s) or disorders contraindicating systemic administration of the therapeutic agent(s) |
| FR3001974B1 (fr) | 2013-02-08 | 2016-02-12 | Olivier Schussler | Procede de purification de cellules |
| RU2522816C1 (ru) * | 2013-02-12 | 2014-07-20 | Российская Федерация, от имени которой выступает Министерство промышленности и торговли Российской Федерации (Минпромторг России) | Композиция для клеточно-заместительной терапии дефектов мягких тканей |
| US10279012B2 (en) * | 2013-03-11 | 2019-05-07 | Healthpartners Research & Education | Methods of treating and preventing social communication disorder in patients by intranasal administration of insulin |
| JP2016523835A (ja) | 2013-05-15 | 2016-08-12 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 中枢神経系へのアデノ随伴ウイルスを介した遺伝子導入 |
| US20170216286A1 (en) | 2014-01-28 | 2017-08-03 | Mayo Foundation For Medical Education And Research | Killing senescent cells and treating senescence-associated conditions using a src inhibitor and a flavonoid |
| US9993472B2 (en) | 2014-01-28 | 2018-06-12 | Unity Biotechnology, Inc. | Treatment for osteoarthritis in a joint by administering a means for inhibiting MDM2 |
| CA2942172A1 (en) * | 2014-03-06 | 2015-09-11 | Children's National Medical Center | Treatment of neonatal brain injury with hb-egf |
| KR102510426B1 (ko) * | 2014-07-29 | 2023-03-15 | 피터 에덴호퍼 | 약의 전달을 위한 정압 호흡기 디바이스 |
| US11413408B2 (en) | 2014-07-29 | 2022-08-16 | Peter Edenhoffer | Positive pressure inspiration device for delivery of medicaments |
| US10130657B2 (en) | 2015-02-13 | 2018-11-20 | John C. Hughes | Formulation, apparatus, and methods for treatment of brain trauma |
| US10335435B2 (en) | 2015-05-22 | 2019-07-02 | Marco Merida | Method for endoscopically delivering stem cells to the brain using an intranasal, injectable approach |
| US20160361253A1 (en) * | 2015-06-13 | 2016-12-15 | Noveome Biotherapeutics, Inc. | Novel Methods for Delivering Therapeutic Agents to the Eye via Nasal Passages |
| WO2017011326A1 (en) | 2015-07-10 | 2017-01-19 | Sanjay Gupta | Nasal foam via cribriform plate for medication delivery to the brain and/or body and for nasal moisturization and hygiene |
| ES2938089T3 (es) * | 2015-08-13 | 2023-04-04 | Takeda Pharmaceuticals Co | Tubos de extracción de sangre al vacío que contienen inhibidores de proteasa para la evaluación de la activación del sistema de contacto |
| US11253612B2 (en) | 2016-04-15 | 2022-02-22 | The Trustees Of The University Of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type II |
| CN106924286A (zh) * | 2017-02-16 | 2017-07-07 | 上海安集协康生物技术股份有限公司 | 一种经鼻腔给药用于帕金森病治疗的神经干细胞制剂 |
| CN108732355B (zh) * | 2017-04-25 | 2021-06-25 | 首都医科大学附属北京安定医院 | 一种测定bace1酶切nrg1活性的检测方法及其试剂盒 |
| US20190060109A1 (en) * | 2017-08-31 | 2019-02-28 | Gregory Todd Johnson | Method of Preventing Traumatic Brain Injury (TBI) |
| EP3684938A1 (en) | 2017-09-22 | 2020-07-29 | The Trustees of the University of Pennsylvania | Gene therapy for treating mucopolysaccharidosis type ii |
| CN108096280A (zh) * | 2017-12-28 | 2018-06-01 | 上海安集协康生物技术股份有限公司 | 一种神经干细胞滴鼻剂 |
| KR20220005900A (ko) * | 2020-07-07 | 2022-01-14 | 가톨릭대학교 산학협력단 | 뇌신경계질환 예방 또는 치료용 약학적 조성물 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5624898A (en) * | 1989-12-05 | 1997-04-29 | Ramsey Foundation | Method for administering neurologic agents to the brain |
| US20040266715A1 (en) * | 1999-03-31 | 2004-12-30 | Wong Liang Fong | Neurite regeneration |
| US6667176B1 (en) * | 2000-01-11 | 2003-12-23 | Geron Corporation | cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells |
| WO2000033813A1 (en) * | 1998-12-09 | 2000-06-15 | Chiron Corporation | Administration of neurotrophic agents to the central nervous system |
| ATE407695T1 (de) * | 1999-02-09 | 2008-09-15 | Riken | Tumorimpfstoff |
| US6749850B1 (en) * | 1999-08-18 | 2004-06-15 | The General Hospital Corporation | Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| US20020169102A1 (en) * | 2001-04-03 | 2002-11-14 | Frey William H. | Intranasal delivery of agents for regulating development of implanted cells in the CNS |
| JP3886346B2 (ja) * | 2001-06-22 | 2007-02-28 | サンバイオ,インコーポレイティド | 骨髄間質細胞由来Schwann細胞を含む神経再生用医薬組成物 |
| EP1438942A1 (en) | 2003-01-17 | 2004-07-21 | Schering Oy | An otorhinological drug delivery device |
| EP1709151B1 (en) * | 2003-12-02 | 2016-04-13 | Celavie Biosciences, LLC | Compositions and methods for propagation of neural progenitor cells |
| WO2007002664A2 (en) * | 2005-06-22 | 2007-01-04 | Massachusetts Institute Of Technology | Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
| US9456979B2 (en) * | 2006-04-27 | 2016-10-04 | Sri International | Adminstration of intact mammalian cells to the brain by the intranasal route |
| US8168169B2 (en) * | 2006-08-09 | 2012-05-01 | Mclean Hospital Corporation | Methods and compositions for the treatment of medical disorders |
| US8283160B2 (en) | 2007-09-11 | 2012-10-09 | Frey Ii William H | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
-
2008
- 2008-04-24 US US12/109,066 patent/US8283160B2/en active Active
- 2008-09-04 MY MYPI2010001011A patent/MY154061A/en unknown
- 2008-09-04 HR HRP20120560AT patent/HRP20120560T1/hr unknown
- 2008-09-04 SG SG2012066049A patent/SG184724A1/en unknown
- 2008-09-04 WO PCT/US2008/075223 patent/WO2009035901A1/en not_active Ceased
- 2008-09-04 DK DK08831016.4T patent/DK2200621T3/da active
- 2008-09-04 CA CA2696892A patent/CA2696892C/en active Active
- 2008-09-04 KR KR1020157002065A patent/KR20150039197A/ko not_active Ceased
- 2008-09-04 PT PT08831016T patent/PT2200621E/pt unknown
- 2008-09-04 MX MX2010002738A patent/MX2010002738A/es active IP Right Grant
- 2008-09-04 ES ES08831016T patent/ES2388403T3/es active Active
- 2008-09-04 RU RU2010113932/15A patent/RU2468818C2/ru active
- 2008-09-04 JP JP2010524134A patent/JP5600294B2/ja active Active
- 2008-09-04 UA UAA201002678A patent/UA98507C2/ru unknown
- 2008-09-04 PL PL08831016T patent/PL2200621T3/pl unknown
- 2008-09-04 AT AT08831016T patent/ATE554778T1/de active
- 2008-09-04 KR KR1020107007866A patent/KR101504110B1/ko active Active
- 2008-09-04 SI SI200830702T patent/SI2200621T1/sl unknown
- 2008-09-04 CN CN200880107049A patent/CN101801397A/zh active Pending
- 2008-09-04 EP EP08831016A patent/EP2200621B1/en active Active
- 2008-09-04 CN CN2012105792811A patent/CN103181932A/zh active Pending
- 2008-09-04 BR BRPI0816325A patent/BRPI0816325B8/pt active IP Right Grant
- 2008-09-04 AU AU2008299124A patent/AU2008299124B2/en active Active
-
2010
- 2010-03-09 IL IL204371A patent/IL204371A/en active IP Right Grant
- 2010-03-09 CR CR11304A patent/CR11304A/es unknown
-
2012
- 2012-07-20 CY CY20121100643T patent/CY1113120T1/el unknown
- 2012-10-08 US US13/647,066 patent/US20130028874A1/en not_active Abandoned
-
2014
- 2014-03-03 JP JP2014040359A patent/JP2014098051A/ja not_active Withdrawn
-
2016
- 2016-03-28 US US15/082,210 patent/US9445991B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101504110B1 (ko) | 동물 중추신경계에 치료세포를 투여하는 방법, 약학 조성물 및 제조 물품 | |
| JP2010539084A5 (cg-RX-API-DMAC7.html) | ||
| US10286015B2 (en) | Methods for treating traumatic brain injury with amnion-derived cellular cytokine solution (ACCS) or amnion-derived multipotent progenitor (AMP) cells | |
| US20020169102A1 (en) | Intranasal delivery of agents for regulating development of implanted cells in the CNS | |
| US6264941B1 (en) | Compositions for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules | |
| US20140255462A1 (en) | Xenotransplant Compositions and Methods of Stroke Therapy | |
| CN103028110B (zh) | 抗分泌因子的新用途 | |
| US20230242870A1 (en) | Cranial nerve disorder therapeutic agent including culture supernatant of tissue cells derived from fetal appendage | |
| TW202116293A (zh) | 免疫調節劑改善神經再生之用途 | |
| Dori et al. | Seven days post-injury fate and effects of genetically labelled adipose-derived mesenchymal cells on a rat traumatic brain injury experimental model | |
| US20240012011A1 (en) | Methods and assays for secretome activity analysis | |
| US20090047325A1 (en) | Xenotransplant for cns therapy | |
| Emerich et al. | In vitro culture duration does not impact the ability of encapsulated choroid plexus transplants to prevent neurological deficits in an excitotoxin-lesioned rat model of Huntington's disease | |
| HK1182932A (en) | Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system | |
| EP1109887A1 (en) | Production and use of dopaminergic cells to treat dopaminergic deficiencies | |
| WO2010060928A2 (en) | Compositions for the treatment of ischemic tissue damage |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A107 | Divisional application of patent | ||
| PA0104 | Divisional application for international application |
St.27 status event code: A-0-1-A10-A16-div-PA0104 St.27 status event code: A-0-1-A10-A18-div-PA0104 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
St.27 status event code: A-1-2-D10-D21-exm-PE0902 |
|
| PE0601 | Decision on rejection of patent |
St.27 status event code: N-2-6-B10-B15-exm-PE0601 |
|
| P22-X000 | Classification modified |
St.27 status event code: A-2-2-P10-P22-nap-X000 |